|
PIK3R2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.56913999999064E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.215200E-03 |
| Normal-vs-Stage2 |
2.643900E-02 |
| Normal-vs-Stage3 |
7.462300E-03 |
| Normal-vs-Stage4 |
1.648250E-01 |
| Stage1-vs-Stage2 |
2.615200E-01 |
| Stage1-vs-Stage3 |
1.349970E-01 |
| Stage1-vs-Stage4 |
4.391000E-01 |
| Stage2-vs-Stage3 |
8.841000E-01 |
| Stage2-vs-Stage4 |
8.056400E-01 |
| Stage3-vs-Stage4 |
8.761800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.18019999999042E-05 |
| Normal-vs-AfricanAmerican |
2.706400E-02 |
| Normal-vs-Asian |
8.532600E-01 |
| Caucasian-vs-AfricanAmerican |
4.207200E-01 |
| Caucasian-vs-Asian |
3.029800E-01 |
| AfricanAmerican-vs-Asian |
4.774600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.823200E-04 |
| Normal-vs-Female |
1.39379999986033E-07 |
| Male-vs-Female |
3.860800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.054110E-02 |
| Normal-vs-Extreme_Weight |
1.253500E-02 |
| Normal-vs-Obese |
2.640700E-03 |
| Normal-vs-Extreme_Obese |
3.577800E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.327000E-01 |
| Normal_Weight-vs-Obese |
8.101200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.580200E-02 |
| Extreme_Weight-vs-Obese |
3.415000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.562100E-02 |
| Obese-vs-Extreme_Obese |
1.388780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.832390E-02 |
| Normal-vs-Age(41-60Yrs) |
1.81804999999091E-05 |
| Normal-vs-Age(61-80Yrs) |
5.760100E-03 |
| Normal-vs-Age(81-100Yrs) |
4.214200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.599650E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.352400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.608500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.769600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.144400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.275000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.00800000000179E-05 |
| Normal-VS-Type2 PRCC |
3.107700E-02 |
| Normal-VS-KIRP CIMP |
5.253900E-02 |
| Normal-VS-Unclassified PRCC |
5.859600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.628000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.056000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.069200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.974010E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.240800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.574600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.599600E-02 |
| Normal-vs-N1 |
8.600200E-03 |
| Normal-vs-N2 |
7.457900E-02 |
| N0-vs-N1 |
4.502800E-01 |
| N0-vs-N2 |
2.872800E-01 |
| N1-vs-N2 |
4.301000E-01 |
|
|
